Growth Metrics

Armata Pharmaceuticals (ARMP) Payables: 2013-2018

Historic Payables for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $714,000.

  • Armata Pharmaceuticals' Payables fell 44.74% to $714,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $4.2 million, marking a year-over-year decrease of 53.78%. This contributed to the annual value of $2.0 million for FY2017, which is 43.90% down from last year.
  • Per Armata Pharmaceuticals' latest filing, its Payables stood at $714,000 for Q3 2018, which was up 4.69% from $682,000 recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Payables ranged from a high of $3.6 million in Q4 2016 and a low of $682,000 during Q2 2018.
  • Moreover, its 3-year median value for Payables was $2.0 million (2017), whereas its average is $2.0 million.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Payables surged by 153.26% in 2016, and later crashed by 72.72% in 2018.
  • Armata Pharmaceuticals' Payables (Quarterly) stood at $1.2 million in 2014, then grew by 20.99% to $1.4 million in 2015, then surged by 153.26% to $3.6 million in 2016, then tumbled by 43.90% to $2.0 million in 2017, then tumbled by 44.74% to $714,000 in 2018.
  • Its Payables stands at $714,000 for Q3 2018, versus $682,000 for Q2 2018 and $810,000 for Q1 2018.